08-Aug-2019
Download PDF
Vivanza Bioscience
The Board of Directors has considered and approved: Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30 2019 along with Limited Review Report thereon and other businesses as mentioned in the outcome attached herewith.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
